Unlock all Features See Plans and Pricing

Serving leading biopharmaceutical companies globally:

Colorcon
Moodys
Merck
Johnson and Johnson
Harvard Business School
Dow

Last Updated: September 26, 2022

Naphazoline hydrochloride; pheniramine maleate - Generic Drug Details


✉ Email this page to a colleague

« Back to Dashboard

▶ Start for $1
Remove trial restrictions


What are the generic sources for naphazoline hydrochloride; pheniramine maleate and what is the scope of freedom to operate?

Naphazoline hydrochloride; pheniramine maleate is the generic ingredient in four branded drugs marketed by Akorn, Altaire Pharms Inc, Alcon, Bausch And Lomb, and Johnson And Johnson, and is included in five NDAs. Additional information is available in the individual branded drug profile pages.

Eleven suppliers are listed for this compound.

Summary for naphazoline hydrochloride; pheniramine maleate
Recent Clinical Trials for naphazoline hydrochloride; pheniramine maleate

Identify potential brand extensions & 505(b)(2) entrants

SponsorPhase
EMSPhase 3

See all naphazoline hydrochloride; pheniramine maleate clinical trials

US Patents and Regulatory Information for naphazoline hydrochloride; pheniramine maleate

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Johnson And Johnson VISINE naphazoline hydrochloride; pheniramine maleate SOLUTION/DROPS;OPHTHALMIC 020485-001 Jan 31, 1996 OTC Yes Yes See Plans and Pricing See Plans and Pricing See Plans and Pricing
Akorn NAPHAZOLINE HYDROCHLORIDE AND PHENIRAMINE MALEATE naphazoline hydrochloride; pheniramine maleate SOLUTION/DROPS;OPHTHALMIC 202795-001 Jan 24, 2013 OTC No No See Plans and Pricing See Plans and Pricing See Plans and Pricing
Alcon NAPHCON-A naphazoline hydrochloride; pheniramine maleate SOLUTION/DROPS;OPHTHALMIC 020226-001 Jun 8, 1994 OTC Yes Yes See Plans and Pricing See Plans and Pricing See Plans and Pricing
Altaire Pharms Inc NAPHAZOLINE HYDROCHLORIDE AND PHENIRAMINE MALEATE naphazoline hydrochloride; pheniramine maleate SOLUTION/DROPS;OPHTHALMIC 078208-001 Sep 27, 2010 OTC No No See Plans and Pricing See Plans and Pricing See Plans and Pricing
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Exclusivity Expiration

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Dow
McKinsey
Medtronic
Moodys
Mallinckrodt
Boehringer Ingelheim

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.